Show Menu

A fully integrated developer and manufacturer of ovine polyclonal therapeutics, targeting infectious disease and acute toxic events

Single Investment Fund Award (SIF)

MicroPharm is pleased to announce that it has been awarded a SIF grant of £200,000 by the Welsh Assembly to support its continued research into new applications of therapeutic ovine polyclonal antibodies for the prevention and treatment of Clostridium  difficile infections.

Posted on: Wednesday, 18th August 2010